Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2015-12-25 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
ALKs partner, Torii, indsender registreringsansøgning for tabletvaccine mod cedertræsallergi i Japan
Regulatory Filings Classification · 75% confidence The document is a GlobeNewswire press release by ALK announcing that its partner Torii has submitted a marketing authorization application for an allergy tablet vaccine in Japan. It contains no financial data, no voting or dividend information, no management or board changes, no earnings figures, and is not itself a formal financial report. It is a general corporate announcement regarding a product regulatory submission, thus falling into the fallback category of Regulatory Filings (RNS).
2015-12-25 Danish
ALKs partner, Torii, indsender registreringsansøgning for tabletvaccine mod cedertræsallergi i Japan
Regulatory Filings Classification · 95% confidence The document is a company release (No 24/2015) announcing that a partner, Torii, has submitted a New Drug Application (NDA) for a cedar SLIT-tablet in Japan. This is a corporate announcement regarding business operations and regulatory progress, which does not fit into specific categories like financial reports, dividends, or shareholder meetings. Therefore, it is classified as a general regulatory announcement (RNS).
2015-12-25 English
Regulatory Filings 2015
Regulatory Filings
2015-12-21 Danish
M&A Activity 2015
M&A Activity Classification · 99% confidence The document is titled "Selskabsmeddelelse nr. 23/2015" (Company Announcement No. 23/2015) and details a specific corporate action: the divestiture (frasælge) of the European veterinary business to Fidelio Capital. This type of announcement, which concerns a significant transaction like a divestiture or merger/takeover activity, aligns best with the M&A Activity (TAR) category. Although it is a regulatory announcement, the specific nature of the content (divestiture/sale of a business unit) makes TAR more precise than the general Regulatory Filings (RNS) fallback. The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2015-12-21 English
ALK frasælger sin europæiske veterinærforretning
M&A Activity Classification · 100% confidence The document is a company release announcing the divestment of a business unit (the European veterinary business). This falls under M&A activity as it describes a transaction, the buyer, and the strategic rationale for the sale. It is not a report publication announcement, but rather the announcement of the transaction itself.
2015-12-21 English
ALK frasælger sin europæiske veterinærforretning
M&A Activity Classification · 85% confidence The document is a press release announcing ALK’s agreement to divest its European veterinary business, detailing the transaction terms, advisor involvement, and impact on guidance. This constitutes an M&A activity announcement (divestment of a business unit).
2015-12-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.